Mechanism of PKM2 affecting cancer immunity and metabolism in Tumor Microenvironment

34Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

PKM2 is the enzyme that regulates the final rate-limiting step of glycolysis. PKM2 expression can reinforce the utilization of oxygen and synthesis of growth substances in cancer cells by enhancing OXPHOS and the Warburg effect. In cancer immunity, PKM2 can modulate the expression of PD-L1 in M2 macrophage and decrease the amount and activity of CD8+ T cells. This affects cancer cell killing and immune escape sequentially. How PKM2 regulates PD-L1 expression through immunometabolism is summarized. PKM2 builds a bridge between energy metabolism and cancer immunity. The activator and inhibitor of PKM2 both promote the anti-cancer immune response and inhibit cancer growth and metastasis by regulating the metabolism of cancer cells and immune cells in the tumor microenvironment through HIF-1α/PKM2 pathway. This review focuses on the precise role of PKM2 modulating immunometabolism, providing valuable suggestions for further study in this field.

Author supplied keywords

Cite

CITATION STYLE

APA

Chen, M., Liu, H., Li, Z., Ming, A. L., & Chen, H. (2021). Mechanism of PKM2 affecting cancer immunity and metabolism in Tumor Microenvironment. Journal of Cancer. Ivyspring International Publisher. https://doi.org/10.7150/JCA.54430

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free